Small, dense lipoprotein particles and reduced paraoxonase-1 in patients with the metabolic syndrome

70Citations
Citations of this article
27Readers
Mendeley users who have this article in their library.

Abstract

The presence of the metabolic syndrome (World Health Organization definition) and its association with lipoprotein abnormalities suggestive of greater susceptibility to oxidative stress have been analyzed in patients with angiographically defined coronary artery disease. The odds ratio for the presence of the metabolic syndrome was significantly higher in coronary artery disease-positive patients (P < 0.001). The metabolic syndrome was also associated with more severe coronary disease (P < 0.01). Patients with the metabolic syndrome had significantly decreased low-density lipoprotein- cholesterol/apolipoprotein B and high-density lipoprotein-cholesterol/ apolipoprotein AI ratios, indicative of the presence of small, dense lipoprotein particles. The syndrome was also associated with reduced concentrations and activities of the antioxidant enzyme, paraoxonase-1. The metabolic syndrome is characterized by smaller, denser lipoprotein particles that increase their susceptibility to oxidative modifications and diminished serum paraoxonase-1, which is a major determinant of the antioxidant capacity of high-density lipoproteins. These may be contributory factors to the increased presence and severity of coronary disease in such patients. Copyright © 2005 by The Endocrine Society.

References Powered by Scopus

Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

27800Citations
N/AReaders
Get full text

Role of insulin resistance in human disease

11637Citations
N/AReaders
Get full text

Prevalence of the metabolic syndrome among US adults: Findings from the Third National Health and Nutrition Examination Survey

5973Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Oxidative stress and metabolic syndrome

694Citations
N/AReaders
Get full text

Functionally defective high-density lipoprotein: A new therapeutic target at the crossroads of dyslipidemia, inflammation, and atherosclerosis

630Citations
N/AReaders
Get full text

Human paraoxonase-1 overexpression inhibits atherosclerosis in a mouse model of metabolic syndrome

156Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Garin, M. C. B., Kalix, B., Morabia, A., & James, R. W. (2005). Small, dense lipoprotein particles and reduced paraoxonase-1 in patients with the metabolic syndrome. Journal of Clinical Endocrinology and Metabolism, 90(4), 2264–2269. https://doi.org/10.1210/jc.2004-1295

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 10

45%

Researcher 9

41%

Professor / Associate Prof. 2

9%

Lecturer / Post doc 1

5%

Readers' Discipline

Tooltip

Agricultural and Biological Sciences 7

35%

Medicine and Dentistry 6

30%

Biochemistry, Genetics and Molecular Bi... 6

30%

Chemistry 1

5%

Save time finding and organizing research with Mendeley

Sign up for free